BF844
Product Specifications
CAS Number
1404506-35-9
Target
HSP, Others
Related Pathways
Others, Cytoskeletal Signaling, Metabolism
Bioactivity
BF844 is a chemical compound that demonstrates the ability to mitigate hearing loss in individuals with Usher Syndrome Type III (USH3) caused by the CLRN1 mutation (specifically N48K) . One of its mechanisms of action is the transportation of CLRN1 N48K to the plasma membrane. In vivo studies have shown that BF844 significantly preserves hearing [1].
Smiles
ClC1=C2C(N(CC(C)(C)O)N=C2C3=CC=CC=C3)=NN=C1C4=CC=CC=C4
Molecular Formula
C21H19ClN4O
Molecular Weight
378.85
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
CSB-EP002503HU-01 20 µg
Recombinant Human UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 (B3GNT5), partial
Sign In for Pricing
View Details CSB-EP002503HU-02 100 µg
Recombinant Human UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 (B3GNT5), partial
Sign In for Pricing
View Details CSB-EP002503HU-03 1 mg
Recombinant Human UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 (B3GNT5), partial
Sign In for Pricing
View Details 
GTR15286594 1 Vial
Lentiviral mouse Epc2 shRNA (UAS) - Lentiviral mouse Epc2 shRNA (UAS, GFP) plasmid
Sign In for Pricing
View Details